Balaraman Kalyanaraman

Centre National de la Recherche Scientifique

H指数:100

被引数:3.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Redox and structural determinants of mitochondrial complex III inhibition by triphenylphosphonium-conjugated atovaquone analogs

三苯基膦共轭阿托喹酮类似物抑制线粒体复合物III的氧化还原和结构决定因素

Redox Biology

IF11.9

2026-08-280

OAAI

Microbial Metabolism of Levodopa as an Adjunct Therapeutic Target in Parkinson’s Disease

Antioxidants

IF6.6

2026-01-170

OAAI

The role of short-chain fatty acids in cancer prevention and cancer treatment

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

IF3

2024-11-014

OAAI

Mitigating gut microbial degradation of levodopa and enhancing brain dopamine: Implications in Parkinson's disease

COMMUNICATIONS BIOLOGY

IF5.1

2024-05-301

OAAI

Characterizing OXPHOS inhibitor-mediated alleviation of hypoxia using high-throughput live cell-imaging

CANCER & METABOLISM

IF5.3

2024-05-033

OAAI

Mito-metformin protects against mitochondrial dysfunction and dopaminergic neuronal degeneration by activating upstream PKD1 signaling in cell culture and MitoPark animal models of Parkinson's disease

FRONTIERS IN NEUROSCIENCE

IF3.2

2024-02-213

OAAI

Redox-crippled MitoQ potently inhibits breast cancer and glioma cell proliferation: A negative control for verifying the antioxidant mechanism of MitoQ in cancer and other oxidative pathologies

FREE RADICAL BIOLOGY AND MEDICINE

IF8.2

2023-08-012

OAAI

Antiproliferative effects of mitochondria-targeted N-acetylcysteine and analogs in cancer cells

SCIENTIFIC REPORTS

IF3.9

2023-05-042

OAAI

Mechanisms by which Mito-lonidamine inhibits EGFR mutant lung cancer

CANCER RESEARCH

IF16.6

2023-04-040

PRE

The Chemistry of HNO: Mechanisms and Reaction Kinetics

HNO的化学: 机理和反应动力学

FRONTIERS IN CHEMISTRY

IF4.2

2022-07-0515

OAAI

Therapeutic Targeting of Tumor Cells and Tumor Immune Microenvironment Vulnerabilities

FRONTIERS IN ONCOLOGY

IF3.3

2022-06-0814

OAAI

Combining PEGylated mito-atovaquone with MCT and Krebs cycle redox inhibitors as a potential strategy to abrogate tumor cell proliferation

SCIENTIFIC REPORTS

IF3.9

2022-03-2411

OAAI

Prevention of Tumor Growth and Dissemination by In Situ Vaccination with Mitochondria-Targeted Atovaquone

通过线粒体靶向的Atovaquone原位疫苗预防肿瘤的生长和传播

ADVANCED SCIENCE

IF14.1

2022-03-0426

OAAI

Exploiting the tumor immune microenvironment and immunometabolism using mitochondria-targeted drugs: Challenges and opportunities in racial disparity and cancer outcome research

FASEB JOURNAL

IF4.2

2022-03-0215

On the chemical reactivity of tricyanofuran(TCF)-based near-infrared fluorescent redox probes-Effects of glutathione on the probe response and product fluorescence

基于三氰基呋喃 (TCF) 的近红外荧光氧化还原探针的化学反应性-谷胱甘肽对探针响应和产物荧光的影响

DYES AND PIGMENTS

IF4.2

2021-08-0115

PREAI

Functionalized polyanhydride nanoparticles for improved treatment of mitochondrial dysfunction

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS

IF3.4

2021-07-2712

PREAI

Reactive oxygen species, proinflammatory and immunosuppressive mediators induced in COVID-19: overlapping biology with cancer

新型冠状病毒肺炎诱导的活性氧，促炎和免疫抑制介质: 与癌症重叠的生物学

RSC CHEMICAL BIOLOGY

IF3.1

2021-01-0110

OAAI

Alcohol-induced CYP2E1, mitochondrial dynamics and retrograde signaling in human hepatic 3D organoids

FREE RADICAL BIOLOGY AND MEDICINE

IF8.2

2020-11-0119

PREAI

Oxidation of ethidium-based probes by biological radicals: mechanism, kinetics and implications for the detection of superoxide

SCIENTIFIC REPORTS

IF3.9

2020-10-2919

OAAI

Potent inhibition of tumour cell proliferation and immunoregulatory function by mitochondria-targeted atovaquone

SCIENTIFIC REPORTS

IF3.9

2020-10-2136

OAAI

Balaraman Kalyanaraman

个人简介

教育背景

工作经历

荣誉奖项

研究方向